BTC Capital Management’s Catalyst Pharmaceutical CPRX Stock Holding History

BTC Capital Management’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$626K	Buy	19,921 +126	+0.6%	+$3.72K	0.04%	167
2026 Q1	$490K	Buy	19,795 +1,100	+6%	+$26.2K	0.03%	175
2025 Q4	$437K	Sell	18,695 -3,404	-15%	-$75.8K	0.03%	178
2025 Q3	$435K	Buy	22,099 +6,954	+46%	+$143K	0.03%	176
2025 Q2	$327K	Sell	15,145 -1,087	-7%	-$25.7K	0.03%	186
2025 Q1	$394K	Sell	16,232 -865	-5%	-$19.5K	0.04%	173
2024 Q4	$357K	Buy	17,097 +258	+2%	+$5.54K	0.03%	181
2024 Q3	$335K	Buy	+16,839	New	+$312K	0.03%	195
2023 Q3	$218K	Sell	18,639 -1,643	-8%	-$22K	0.03%	226
2023 Q2	$275K	Buy	+20,282	New	+$292K	0.03%	208

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

BTC Capital Management's CPRX Position: Q2 2026 in Review

BTC Capital Management increased its Catalyst Pharmaceutical (CPRX) stake by 0.64% in Q2 2026, buying an estimated $3.72K and bringing the position to 19,921 shares worth $626K. The position accounts for 0.04% of the portfolio, ranked #167.

BTC Capital Management first reported a position in CPRX in Q2 2023 and has held it in 10 quarters since. 36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

BTC Capital Management held 19,921 shares of Catalyst Pharmaceutical worth $626K as of Q2 2026.
BTC Capital Management bought 126 Catalyst Pharmaceutical shares in Q2 2026, an estimated $3.72K.
Catalyst Pharmaceutical made up 0.04% of BTC Capital Management's portfolio in Q2 2026, its #167 holding.
BTC Capital Management first reported a position in Catalyst Pharmaceutical in Q2 2023 and has held it in 10 quarters since.
36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on BTC Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.